S. 974 · 115th Congress
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
30 cosponsors · 14 D, 15 R, 1 I
11 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017
What it does: CRS summary · Introduced in Senate · Apr 27, 2017
Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017
This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Also known as: CREATES Act of 2017; CREATES Act of 2018; Creating and Restoring Equal Access To Equivalent Samples Act of 2017
Latest action (Jun 21, 2018): Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.
Policy area: Health · Origin: Senate · Introduced: Apr 27, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.